Long-term Mechanical Circulatory Support (Destination Therapy): On Track to Compete with Heart Transplantation?
Average 2-year survival after cardiac transplantation is approximately 80%.
You may also like
Healthcare Failure Mode Effect Analysis of a Miniaturized Extracorporeal Bypass Circuit
The technique of hFMEA is a valuable tool in evaluating the use of high-risk apparatus
1 min read
High Incidence of Antibodies to Protamine and Protamine/Heparin Complexes in Patients Undergoing Cardiopulmonary Bypass
We hypothesized that patients exposed to protamine and heparin during CPB will develop antibodies (Abs) to protamine/heparin (PRT/H) complexes that are capable of platelet activation.
1 min read